Organization Profile

You just read:

Largest study of low molecular weight heparin in patients with venous thromboembolism (VTE) and severe renal impairment showed full dose innohep (tinzaparin) was not associated with accumulation or increased risk of major bleeding

News provided by

LEO Pharma

Dec 07, 2016, 18:34 ET